Drug Safety Update
December 2014: Cyproterone acetate with ethinylestradiol (co-cyprindiol): balance of benefits and risks remains positive.
December 2014: High-dose cyproterone acetate: potential risk of (multiple) meningiomas.
April 2020: Restrictions in use of cyproterone acetate due to risk of meningioma
June 2020: Cyproterone acetate: new advice to minimise risk of meningioma